Stock listing
Galera Therapeutics, Inc.
Selected listing: GRTX · OTC · USD · US
Galera Therapeutics, Inc. (OTC:GRTX), Health Technology. Latest release Apr 14, 2026: Galera Therapeutics and Obsidian Therapeutics Announce Merger Agreement…
- Ticker
- OTC:GRTX
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- OTC
- Currency
- USD
About Galera Therapeutics, Inc.
Galera Therapeutics, Inc. is a public company traded under the ticker GRTX in the American market. Galera focuses on developing innovative therapies to improve patient outcomes in cancer treatment.
Latest news from Galera Therapeutics, Inc.
Galera Therapeutics and Obsidian Therapeutics Announce Merger Agreement and $350 Million Concurrent Private Placement
April 14, 2026
Obsidian Therapeutics and Galera Therapeutics Announce Merger Agreement and $350 Million Concurrent Private Placement
April 14, 2026
Neogen® Corporation Announces Appointment of Jennifer Evans Stacey as Chief Legal & Compliance Officer and Board Secretary
April 8, 2026
Galera Therapeutics Announces Acquisition of Dismutase Mimetics Portfolio by Toronto-based Biossil for up to $105 Million
October 22, 2025
OTC Markets Group Welcomes New OTCQB Companies – June 9
June 8, 2025
Research Galera Therapeutics, Inc.
Galera Therapeutics, Inc. company profile
View the public company page for Galera Therapeutics, Inc. on 6ix.
Galera Therapeutics, Inc. news
Read company news and market updates connected to Galera Therapeutics, Inc..
Galera Therapeutics, Inc. investor events
Find investor webinars, events, and replay context for Galera Therapeutics, Inc..